EKF DIAGNOSTICS HOLDINGS PLC — Director's Dealing 2016

Jun 10, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9160A

EKF Diagnostics Holdings PLC

10 June 2016

10 June 2016

EKF Diagnostics Holdings plc

("EKF" or the "Company")

Director Dealings

EKF Diagnostics Holdings plc (AIM: EKF) announces that on 10 June 2016, the Company was notified that Harwood Capital LLP ("Harwood") acquired 447,666 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT"). Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood and a director and shareholder in NAIT.

Following the above transaction, which was completed on 9 June 2016 at a price of 11.5 pence per share, NAIT's interest is now in 65,395,322 Ordinary Shares, representing 14.09% of the Company's issued share capital. The interests of Oryx International Growth Fund Limited ("Oryx", whose investment adviser is Harwood) remains as previously disclosed in 40,000,000 Ordinary Shares, representing 8.62% of the Company's issued share capital. Mr Mills is also a director and shareholder in Oryx.

The total indirect beneficial interest of Mr Mills is, following the above transaction, therefore now in 105,395,322 Ordinary Shares, representing 22.71% of the Company's issued share capital.

EKF Diagnostics Holdings plc		Tel: 029 2071 0570
Julian Baines, CEO
Richard Evans, FD & COO
Panmure Gordon (UK) Limited		Tel: 020 7886 2500
Robert Naylor (Corporate Finance)
Paul Fincham (Corporate Finance)
Rupert Dearden (Sales)
Walbrook PR Limited	Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus		Mob: 07980 541 893
Lianne Cawthorne		Mob: 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBUGDLIBBBGLG